8 completed. 8 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 2 | Completed 2 |
Follow Arteriovenous Fistula: new trials by email Literature Review of Arteriovenous Fistula trials Research Report on Arteriovenous Fistula
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction Lidocaine Spray: Each ml contained 10 mg lidocaine and ethanol. Applied to the local site to provide anesthesia, Benzocaine spray, Placebo group (control arm) - Pain, Satisfaction | Phase 3 | Completed | TC Erciyes University | 60 | 2024-04-01 | 2025-12-01 |
| A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery Sirolimus - Complication of Renal Dialysis, End Stage Renal Disease | Phase 3 | Completed | Vascular Therapies, Inc. | 136 | 2022-08-26 | 2026-10-06 |
| Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Sirolimus, AV Fistula Surgery, Sirolimus-eluting Collagen Implant (SeCI) - Complication of Renal Dialysis, End Stage Renal Disease | Phase 3 | Completed | Vascular Therapies, Inc. | 269 | 2015-11-01 | 2025-10-09 |
| A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2) Vonapanitase, Placebo - Chronic Kidney Disease | Phase 3 | Completed | Proteon Therapeutics | 696 | 2015-08-01 | 2019-08-13 |
| Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae Lutonix DCB, Standard Balloon Angioplasty Catheter, Percutaneous Transluminal Angiography - Arteriovenous Fistula | Phase 3 | Completed | C. R. Bard | 285 | 2015-06-01 | 2020-05-06 |
| A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1) PRT-201, Placebo - Chronic Kidney Disease | Phase 3 | Completed | Proteon Therapeutics | 349 | 2014-07-01 | 2019-07-09 |
| Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae Venous Window Needle Guide - End Stage Renal Disease, AV Fistula | Phase 2 / Phase 3 | Completed | Vital Access Corp. | 54 | 2011-12-01 | 2016-06-03 |
| A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures. AQUAVAN® (fospropofol disodium) Injection - Procedural Sedation | Phase 2 / Phase 3 | Completed | Eisai Inc. | 123 | 2006-05-01 | 2012-06-20 |
Kidney Failure, Chronic (3) · Renal Insufficiency, Chronic (3) · Bunion (1) · Dilatation, Pathologic (1) · Pain (1) · Personal Satisfaction (1) · Renal Insufficiency (1)
Arteriovenous Malformations (8) · Cardiovascular Abnormalities (8) · Cardiovascular Diseases (8) · Congenital Abnormalities (8) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Fistula (8) · Pathological Conditions, Anatomical (8) · Pathological Conditions, Signs and Symptoms (8) · Vascular Diseases (8) · Vascular Fistula (8) · Vascular Malformations (8) · Chronic Disease (5) · Disease Attributes (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5)
Sirolimus (2) · cholesterol-binding protein (2) · Injections (1) · Lidocaine (1) · fospropofol (1)
Proteon Therapeutics (2) · Vascular Therapies, Inc. (2) · C. R. Bard (1) · Eisai Inc. (1) · TC Erciyes University (1) · Vital Access Corp. (1)
United States (7) · Canada (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Sriram Iyer, MD (2) · James B Jones, MD, PharmD (1) · Mark Crawford, BA (1) · Scott Trerotola, MD (1)
PMID 36567000, PMID 38825327, PMID 24833247, PMID 30042225, PMID 30683197, PMID 33482699